drugset / Trial / NCT06111261

Initial Resuscitation With Albumin in Hemorrhagic Shock to Reduce Positive Fluid Balance

NCT06111261

RandomizedParallel-groupSingle-blindTreatment

Summary

This study is designed to evaluate the effect of early albumin transfusion within massive transfusion protocol on fluid balance and reduced requirement of transfusion.

Timeline

Start
2023-11-15
Primary completion
2025-07-15
Completion
2025-08-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Human serum albumin Protein / enzyme biologic 20 %
Subject Human serum albumin Protein / enzyme biologic 200 ml
Comparator Balanced crystalloid solution Unknown

Indications